Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 14.8
1.44 %
$ 937 M
Market Cap
-16.26
P/E
EOLS - RESEARCH & DEVELOPMENT
Research & Development EOLS - Evolus, Inc.
15.4 M
LAST VALUE
173.37%
2 YEAR CAGR
18.91%
5 YEAR CAGR
0.00%
10 YEAR CAGR